Laxmi Organic Industries (LXCHEM) Q4 24/25 earnings summary

Executive summary

• Achieved 11% year-on-year volume growth and 9.4%–9.5% EBITDA growth, maintaining profitability amid challenging market and geopolitical conditions.

• Growth driven by operational excellence, capacity augmentation, customer-centricity, and prudent cost management.

• Launched a new innovation center and commenced commercial sales at the fluoro intermediate site in Q4 FY25.

• Signed a Letter of Intent with Hitachi Energy, entering a new segment in power transmission and eco-efficient gas production.

• Board approved annual audited results for FY25 with unmodified audit opinions and recommended a final dividend of Rs. 0.50 per share.

Financial highlights

• FY25 consolidated revenue grew 5% year-on-year to INR 29,854 million; Q4 revenue declined 9% year-on-year.

• FY25 EBITDA increased 9% to INR 2,796 million; EBITDA margin at 9.4% (up 41 bps); PAT margin at 3.8%.

• Q4 adjusted EBITDA at INR 590 million (vs. INR 900 million prior year, which included a one-time gain).

• Standalone net profit for FY25: Rs. 1,180.21 million; consolidated net profit: Rs. 1,135.04 million.

• Cash and cash equivalents at FY25 end: consolidated Rs. 416.37 million.

Outlook and guidance

• Targeting to double consolidated revenue and triple EBITDA by FY28, with ROCE of 20%.

• Dahej plant commissioning expected in H2 FY26, with ramp-up into FY27–FY28.

• No equity dilution planned; peak debt expected at INR 300–350 crore, with debt/equity ratio below 0.3.

• Board scheduled the 36th AGM for July 31, 2025.